MediaRadar, Inc.’s Post

As the proliferation of this advertising continues, MediaRadar's legal ad tracking vertical will keep an eye on mass tort solicitation advertising targeting these meds for alleged negative health consequences... https://lnkd.in/em2P9vyG

MediaRadar, Inc. was featured on Bloomberg's Big Take Podcast! 🎧https://gag.gl/QzYbcA Our data reveals a $71 million ad spend by top telehealth companies on weight-loss products this year. As Ozempic copycats become more accessible, this shift raises new challenges for both advertising and eating disorder recovery. Tune in to learn how advertising, regulation, and the telehealth market are evolving in this market. #MediaRadar #Bloomberg #AdvertisingIntellience #Healthcare #Telemedicine

MediaRadar, Inc. was featured on Bloomberg's Big Take Podcast! 🎧https://gag.gl/QzYbcA Our data reveals a $71 million ad spend by top telehealth companies on weight-loss products this year. As Ozempic copycats become more accessible, this shift raises new challenges for both advertising and eating disorder recovery. Tune in to learn how advertising, regulation, and the telehealth market are evolving in this market. #MediaRadar #Bloomberg #AdvertisingIntellience #Healthcare #Telemedicine

MediaRadar, Inc. was highlighted on Bloomberg's Big Take Podcast! 🎧https://gag.gl/QzYbcA Our analysis indicates a $71 million ad expenditure by leading telehealth companies on weight-loss products this year. As Ozempic alternatives become more available, this change introduces new challenges for both advertising and eating disorder recovery. Listen in to discover how advertising, regulation, and the telehealth industry are progressing in this market. #MediaRadar #Bloomberg #AdvertisingIntellience #Healthcare #Telemedicine

MediaRadar, Inc. was highlighted on Bloomberg's Big Take Podcast! 🎧https://gag.gl/QzYbcA Our data indicates that leading telehealth companies have spent $71 million on advertising weight-loss products this year. As Ozempic alternatives become more widely available, this trend presents new challenges for both advertising and eating disorder recovery. Listen in to discover how advertising, regulation, and the telehealth market are changing in this sector. #MediaRadar #Bloomberg #AdvertisingIntellience #Healthcare #Telemedicine

MediaRadar, Inc. was highlighted on Bloomberg's Big Take Podcast! 🎧https://gag.gl/QzYbcA Our data indicates that leading telehealth companies have spent $71 million on advertising weight-loss products this year. As Ozempic alternatives become more widely available, this trend introduces new challenges for both advertising and eating disorder recovery. Listen in to discover how advertising, regulation, and the telehealth market are adapting in this landscape. #MediaRadar #Bloomberg #AdvertisingIntellience #Healthcare #Telemedicine

MediaRadar, Inc. was highlighted on Bloomberg's Big Take Podcast! 🎧https://gag.gl/QzYbcA Our research indicates that leading telehealth companies have spent $71 million on advertising weight-loss products this year. With the increasing availability of Ozempic alternatives, this development presents new challenges for both advertising and eating disorder recovery. Listen in to discover how advertising, regulation, and the telehealth industry are adapting in this market. #MediaRadar #Bloomberg #AdvertisingIntellience #Healthcare #Telemedicine

MediaRadar, Inc. was highlighted on Bloomberg's Big Take Podcast! 🎧https://gag.gl/QzYbcA Our data indicates a $71 million ad expenditure by leading telehealth companies on weight-loss products this year. As Ozempic copycats become more available, this change presents new challenges for both advertising and eating disorder recovery. Listen in to discover how advertising, regulation, and the telehealth market are adapting in this landscape. #MediaRadar #Bloomberg #AdvertisingIntellience #Healthcare #Telemedicine

MediaRadar, Inc. was highlighted on Bloomberg's Big Take Podcast! 🎧https://gag.gl/QzYbcA Our analysis shows a $71 million advertising expenditure by leading telehealth companies on weight-loss products this year. As Ozempic copycats become more widely available, this change presents new challenges for both advertising and eating disorder recovery. Listen in to discover how advertising, regulation, and the telehealth market are adapting in this sector. #MediaRadar #Bloomberg #AdvertisingIntellience #Healthcare #Telemedicine

MediaRadar, Inc. was highlighted on Bloomberg's Big Take Podcast! 🎧https://gag.gl/QzYbcA Our analysis shows a $71 million advertising investment by leading telehealth companies in weight-loss products this year. With Ozempic alternatives becoming more widely available, this development presents new challenges for both advertising and eating disorder recovery. Listen in to discover how advertising, regulation, and the telehealth industry are adapting in this market. #MediaRadar #Bloomberg #AdvertisingIntellience #Healthcare #Telemedicine